Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China flag China · Delayed Price · Currency is CNY
72.61
+0.61 (0.85%)
At close: Sep 18, 2026

SHA:688198 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
623.69617.78500.26369.91295.07251.8
Other Revenue
2.292.371.610.730.10.02
625.98620.15501.88370.64295.17251.82
Revenue Growth
11.94%23.57%35.41%25.57%17.21%38.42%
Cost of Revenue
67.3267.0958.5237.6431.3629.61
Gross Profit
558.65553.06443.35333263.81222.21
Selling, General & Admin
221.35202.29154.92131.97123.77131.16
Research & Development
164.06155.33151.4498.8155.1558.9
Other Operating Expenses
21.246.692.731.251.621.17
Operating Expenses
410.31366.46311.49233.5181.64192.04
Operating Income
148.34186.6131.8699.582.1730.17
Interest Expense
-2.24-1.44-0.46-0.41-0.08-0.12
Interest & Investment Income
9.2410.6217.3217.6622.5316.49
Currency Exchange Gain (Loss)
-2.58-1.070.05-0.260-
Other Non Operating Income (Expenses)
3.91-0.59-0.16-0.06-0.68-0.05
EBT Excluding Unusual Items
156.68194.11148.62116.43103.9446.5
Gain (Loss) on Sale of Investments
0.890.830.7410.890.97
Gain (Loss) on Sale of Assets
-0.07-0-0.050.05-0.01-0.02
Other Unusual Items
17.2211.191.482.541.322.31
Pretax Income
174.72206.13150.79120.02106.1449.76
Income Tax Expense
18.2526.4518.6410.6111.74-1.51
Earnings From Continuing Operations
156.47179.68132.14109.4194.3951.26
Minority Interest in Earnings
9.5813.8914.195.80.73-0.06
Net Income
166.06193.57146.33115.2195.1351.2
Net Income to Common
166.06193.57146.33115.2195.1351.2
Net Income Growth
-9.03%32.28%27.02%21.11%85.80%-9.42%
Shares Outstanding (Basic)
137137137136136135
Shares Outstanding (Diluted)
137137137137136135
Shares Change
-0.39%0.39%-0.29%0.92%0.86%0.44%
EPS (Basic)
1.211.411.070.850.700.38
EPS (Diluted)
1.211.411.070.840.700.38
EPS Growth
-8.67%31.78%27.38%20.00%84.21%-9.82%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12.8361.6-27.0212.5324.014.27
Free Cash Flow Per Share
0.090.45-0.200.090.180.03
Dividend Per Share
0.8000.8000.8000.8000.5000.357
Dividend Growth
0%0%0%60.00%40.02%149.90%
Gross Margin
89.24%89.18%88.34%89.84%89.38%88.24%
Operating Margin
23.70%30.09%26.27%26.85%27.84%11.98%
Profit Margin
26.53%31.21%29.16%31.08%32.23%20.33%
Free Cash Flow Margin
2.05%9.93%-5.38%3.38%8.14%1.70%
EBITDA
188.16224.73151.61110.787.7836.19
EBITDA Margin
30.06%36.24%30.21%29.87%29.74%14.37%
D&A For EBITDA
39.8238.1419.7511.195.616.02
EBIT
148.34186.6131.8699.582.1730.17
EBIT Margin
23.70%30.09%26.27%26.85%27.84%11.98%
Effective Tax Rate
10.45%12.83%12.36%8.84%11.06%-
Revenue as Reported
625.98620.15501.88370.64295.17251.82
Advertising Expenses
-6.662.010.371.121.22